01 · Process stage
PlannedFill material preparation
Define compounding, mixing and deaeration requirements for the proposed liquid or semi-solid fill.
Capabilities · Oral solid dosage forms
Soft capsules
A proposed service scope for softgel presentations, connecting fill-liquid preparation, gelatin or non-gelatin shell formulation, encapsulation and drying stages.
PlannedCatalogue scope
Service statusPlanned
Planned.
Technical boundaries and readiness need confirmation before an activity could be presented as available.
Basis · Catalogue scope
- Status
- PlannedNo available service asserted
- Source-plan relationship
- Catalogue scopeProposed catalogue expansion
- Readiness
- Not establishedProduct and process evidence needed
- Facility roadmap
- First commercial batch target Q1 2028 · indicativeNot a service date
01 · Proposed service scope
Start with the product and its container.
Soft capsule manufacturing is a planned service domain. The specific liquid or semi-solid fill, shell composition and selected technical route would dictate the precise manufacturing scope.
The initial Boten plan prioritises aseptic liquid processing and biological materials. Proposed soft capsule services lie outside that foundational plan and would necessitate separate scope confirmation.
Gelatin and plant-based shell formulations behave differently during encapsulation and drying. A shared catalogue entry does not establish that processing parameters are interchangeable between polymer types.
Catalogue boundary
A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.
02 · Presentation families
Match the route to the format.
| Format | Planning note | Basis | Status |
|---|---|---|---|
| Gelatin soft capsules | Traditional animal-derived shell formulations proposed as a technical extension to the initial plan. | Catalogue scope | Planned |
| Vegetarian soft capsules | Plant-based shell materials would require distinct thermal controls and sealing parameter evaluation. | Catalogue scope | Planned |
| Lipid-filled soft capsulesOral solutions & syrups | Hydrophobic fill matrices would necessitate specific preparation vessels and transfer line controls. | Catalogue scope | Planned |
03 · Process scope for discussion
Make the sequence and its evidence visible.
02 · Process stage
PlannedGel mass formulation
Establish the precise melting, blending and thermal holding parameters for the shell material.
03 · Process stage
PlannedEncapsulation & sealing
Define ribbon thickness, fill volume targets, injection timing and associated thermal sealing temperatures.
04 · Process stage
PlannedInitial cooling & shaping
Assess the immediate post-encapsulation environment required to maintain structural integrity of the capsules.
05 · Process stage
PlannedDrying & curing
Establish specific tumbling and tunnel drying conditions needed to achieve the target moisture limits.
06 · Process stage
PlannedInspection & bulk review
Connect physical inspection data, compiled process records and the accountable decisions for material disposition.
Illustrative sequence
This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.
04 · Supporting services
No service stands alone.
01PlannedCatalogue scope
Suspensions & emulsions
Dispersion, mixing, homogeneity and filling scope.
Explore proposed scope02PlannedCatalogue scope
Primary packaging
Blisters, bottles, sachets, tubes and presentation-specific container systems.
Explore proposed scope03PlannedCatalogue scope
Oral solutions & syrups
Solution preparation, handling and filling considerations.
Explore proposed scope05 · Readiness questions
A service claim needs a defined evidence base.
- Formulation & compatibility
- Exact fill composition and documented compatibility with the intended capsule shell matrix.
- Facility & environmental controls
- Strict ambient temperature and humidity regulation, processing suites and an approved technical scope.
- Process validation evidence
- Defined encapsulation parameters, drying curves and documented evidence of fill weight uniformity.
- Quality responsibilities
- Agreed analytical testing protocols, sampling plans and formal review decision frameworks.
- Regulatory context
- Applicable facility permissions for manufacturing the active substance within a softgel format.
- Technical agreement
- Documented technical boundaries, intellectual property protection and disclosure terms for future engagements.
06 · Practical questions
Before a technical discussion.
Is this service currently available?
No. The service is Planned. This page is a scope proposal and does not establish an operating softgel service.
Are soft capsules part of the initial plan?
No. The primary project plan establishes specific parenteral filling and biological processing. Softgel manufacturing would necessitate distinct scope confirmation.
What information helps define the question?
Outline the proposed fill liquid, shell polymer preference, development stage, market destination and technical query. Confidential material should only be transferred through an established agreement route.
Is there a service launch quarter?
No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual service to a start date.
Does a technical discussion establish supply?
No. Formulation feasibility, precise scope, relevant permissions, manufacturing evidence and a documented agreement would be required before any supply arrangement.
Professional enquiries
Discuss a defined question.
Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.